APOL1 Risk Alleles and Preeclampsia

APOL1 Risk Alleles and Preeclampsia:

The Preeclampsia Risk Indicator You Should Know

Key Takeaways

  • Preeclampsia significantly impacts African American women, leading to higher risks of severe outcomes and maternal mortality.
  • The APOL1 gene contains risk alleles G1 and G2 that are associated with preeclampsia and chronic kidney disease.
  • Genetic variants can increase inflammation, damage blood vessels, and affect both the mother’s and the baby’s risk for preeclampsia.
  • African American women should discuss genetic testing for APOL1 with their doctors and recognize symptoms of preeclampsia.
  • Self-advocacy is crucial; use the ROOT framework to communicate effectively with healthcare providers and take control of health decisions.

Introduction: Understanding Preeclampsia and Its Impact

APOL1 Risk Alleles and Preeclampsia:

Preeclampsia is a serious pregnancy complication characterized by high blood pressure and signs of damage to organ systems, most often the liver and kidneys. Unfortunately, African American women are disproportionately affected by this condition, facing higher rates of severe outcomes and maternal mortality.

While environmental, social, and systemic factors play a massive role in these disparities, genetics is also part of the puzzle. Recently, scientists have taken a closer look at the APOL1 gene and its specific connection to preeclampsia risk in women of African descent.

What Are APOL1 Risk Alleles?

Genes act as the instruction manuals for our bodies. The APOL1 gene has many biological functions, including cholesterol transport and immune regulation.

Within this gene, there are specific variations known as the G1 and G2 “risk alleles.” Thousands of years ago, these specific genetic changes evolved to protect people in regions of Africa from a deadly illness called African sleeping sickness. However, in modern times, carrying these same G1 and G2 variants is linked to an increased risk of chronic kidney disease and preeclampsia.

How Do APOL1 Risk Alleles Affect Preeclampsia Risk?

How does a genetic variation turn a healthy pregnancy into a high-risk one? The science points to a few specific areas:

  • Immune System Overdrive: Because the APOL1 gene plays a role in the immune system, the presence of these risk variants can trigger increased inflammation.
  • Blood Vessel Damage: These genetic variants can alter protein shape, damaging the endothelial cells that line your blood vessels. This damage leads to the dangerous spikes in blood pressure seen in preeclampsia.
  • The Mother-Baby Connection: The baby’s genetics matter just as much. Research shows that if a fetus carries the APOL1 G1 and G2 variants, it increases the risk of the mother developing preeclampsia.

Key Findings about APOL1 and Preeclampsia from Recent Research

For too long, medical research has left Black women behind. Including African American women in genetic studies is how we uncover the truths about our bodies. Here is what recent data shows:

  • Overall, having the APOL1 G1 or G2 risk alleles increases the risk of preeclampsia by 1.70-fold.
  • Maternal APOL1 G1 variants are specifically linked to an increased risk of early-onset preeclampsia.
  • If the mother and fetus have mismatched (discordant) APOL1 genotypes, the maternal risk for preeclampsia is amplified nearly 3-fold.

What African American Women Need to Know & Steps to Take

You cannot change your DNA, but knowing your genetic background equips you to advocate fiercely for your health.

  • Talk to Your Doctor: Ask about your family history and whether genetic testing for APOL1 or other preeclampsia markers is right for you. Testing usually requires a simple blood draw or saliva sample.
  • Understand the Costs: Genetic testing can range from $250 for a single gene to over $1,000 for comprehensive panels. If you are uninsured, ask your clinic about sliding scale fees, check for research studies on ClinicalTrials.gov, or seek financial assistance programs.
  • Recognize the Signs: Always monitor for symptoms like severe headaches, swelling in your face and hands, vision changes, or upper right belly pain.

Resources for Self-Advocacy: Use The ROOT Framework

At Rooted in Violet & Co., we believe self-advocacy is not a skill you’re born with—it’s a practice you grow into. When discussing your risk factors and genetic testing options with a provider, use our signature method to guide the conversation:

  • R – Reveal What’s Going On: Track symptoms, emotions, or health changes in journals or digital logs. Identify triggers, timelines, and patterns that may indicate underlying issues.
  • O – Offer Your Observations: Use specific, fact-based language to describe changes and concerns. Ask questions that clarify next steps and treatment options.
  • O – Outline What You Need: Express preferences regarding diagnostic tests, treatment options, and follow-up care. Request referrals, second opinions, or culturally competent providers.
  • T – Take Note & Follow-Up: Document every conversation, diagnosis, and medical recommendation. Schedule follow-ups and set reminders for screenings or labs.

The Path Forward

Knowledge is power—and protection. By understanding how genetic factors like APOL1 influence maternal health, you are stepping into the driver’s seat of your care plan. We need the medical community to step up, too, by funding more research focused on African American and African populations. This data is essential for building better predictive tools, machine learning models, and equitable care systems.

Conclusion

Remember: your voice is the strongest medicine you have. Your body’s signals are valid and deserve investigation, not dismissal. By staying informed and utilizing the right advocacy tools, we can fight back against health disparities and protect our maternal health.


References

Katsukunya, J. N., Davidson, B., Mnika, K., Soko, N. D., Osman, A., Matjila, M., Jones, E., & Dandara, C. (2026). Preeclampsia Genomic Susceptibility Factors in Populations of African Ancestry: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences, 27(6), 2594. https://doi.org/10.3390/ijms27062594